{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Smits RAL"],"funding":["ZonMw"],"pagination":["1519-1526"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12378732"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(4)"],"pubmed_abstract":["<h4>Purpose</h4>The aim of this study was to validate the acutely presenting older patient (APOP) screener, routinely used on the Emergency Department to predict risk of adverse outcomes in older people, for prediction of in-hospital mortality and 30-days-mortality in older patients hospitalized for COVID-19.<h4>Methods</h4>Patients ≥ 70 years from a multicenter cohort hospitalized for COVID-19 with measured APOP risk were included. External validation analysis of the APOP screener for in-hospital mortality and 30-days-mortality was performed including discrimination and calibration.<h4>Results</h4>389 patients (median age 80 (IQR 75-85) years, 41.4% female, 138 APOP high risk) were included. APOP high risk patients more often lived institutionalized, (26% vs. 4%; p < 0.001), had more como"],"journal":["European geriatric medicine"],"pubmed_title":["Validation of the acutely presenting older patient screener for short term mortality prediction in older patients hospitalized for COVID-19."],"pmcid":["PMC12378732"],"funding_grant_id":["10430102110005"],"pubmed_authors":["Jansen SWM","Mooijaart SP","Polinder-Bos HA","van Smeden M","van der Bol JM","Willems HC","Gussekloo J","van der Linden CMJ","Steyerberg EW","van Raaij BFM","Trompet S","Smits RAL"],"additional_accession":[]},"is_claimable":false,"name":"Validation of the acutely presenting older patient screener for short term mortality prediction in older patients hospitalized for COVID-19.","description":"<h4>Purpose</h4>The aim of this study was to validate the acutely presenting older patient (APOP) screener, routinely used on the Emergency Department to predict risk of adverse outcomes in older people, for prediction of in-hospital mortality and 30-days-mortality in older patients hospitalized for COVID-19.<h4>Methods</h4>Patients ≥ 70 years from a multicenter cohort hospitalized for COVID-19 with measured APOP risk were included. External validation analysis of the APOP screener for in-hospital mortality and 30-days-mortality was performed including discrimination and calibration.<h4>Results</h4>389 patients (median age 80 (IQR 75-85) years, 41.4% female, 138 APOP high risk) were included. APOP high risk patients more often lived institutionalized, (26% vs. 4%; p < 0.001), had more como","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-05-09T17:56:45.116Z","creation":"2026-04-08T01:07:15.221Z"},"accession":"S-EPMC12378732","cross_references":{"pubmed":["40261576"],"doi":["10.1007/s41999-025-01200-4"]}}